Prevalence, pattern, and determinants of musculoskeletal pain among maintenance hemodialysis patients: a cross-sectional analytical study
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20263930Keywords:
Chronic kidney disease-mineral and bone disorder, Functional limitation, Maintenance hemodialysis, Musculoskeletal pain, Pain prevalence, Quality of lifeAbstract
Background: Musculoskeletal pain is common but frequently under-recognized among patients receiving maintenance hemodialysis (MHD). It may impair mobility, sleep, daily activities, functional independence, and participation in dialysis treatment. This study evaluated the prevalence, clinical pattern, functional impact, and determinants of musculoskeletal pain among adults receiving MHD.
Methods: This cross-sectional analytical study included 1,000 consecutive adults receiving MHD who attended the nephrology outpatient department of a tertiary care center between May 2021 and April 2026. Musculoskeletal pain was assessed during a single outpatient visit using an 11-point numerical rating scale and was characterized according to anatomical site, severity, duration, laterality, and functional impact. Demographic, clinical, dialysis-related, nutritional, and chronic kidney disease-mineral and bone disorder variables were compared between participants with and without pain. Independent factors associated with musculoskeletal pain were identified using multivariable logistic regression.
Results: Musculoskeletal pain was reported by 620 participants, corresponding to a prevalence of 62.0%. Moderate pain was most common (54.5%), followed by severe pain (26.5%) and mild pain (19.0%). The knee (54.2%), lower back (46.5%), and shoulder (32.9%) were the most frequently affected sites. Functional limitation and pain-related sleep disturbance were reported by 53.9% and 46.1% of affected participants, respectively. In multivariable analysis, older age (p<0.001), female sex (p=0.041), diabetes mellitus (p=0.002), longer dialysis vintage (p<0.001), higher serum phosphate (p<0.001), higher alkaline phosphatase (p=0.001), higher intact parathyroid hormone (p<0.001), and vitamin D deficiency (p=0.001) were independently associated with greater odds of musculoskeletal pain. Higher hemoglobin (p=0.007) and serum albumin (p=0.003) were independently associated with lower odds of pain.
Conclusions: Musculoskeletal pain affected nearly two-thirds of this MHD population and was frequently accompanied by functional limitation and sleep disturbance. Its independent associations with nutritional status, anemia, dialysis duration, and mineral-bone abnormalities suggest that structured pain assessment and targeted evaluation of potentially modifiable contributors should be incorporated into routine outpatient care of patients receiving maintenance hemodialysis.
Metrics
References
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-33. DOI: https://doi.org/10.1016/S0140-6736(19)32977-0
Weisbord SD, Fried LF, Arnold RM, Fine MJ, Levenson DJ, Peterson RA, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487-94. DOI: https://doi.org/10.1681/ASN.2005020157
Davison SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42(6):1239-47. DOI: https://doi.org/10.1053/j.ajkd.2003.08.025
Brkovic T, Burilovic E, Puljak L. Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review. Patient Prefer Adher. 2016;10:1131-50. DOI: https://doi.org/10.2147/PPA.S103927
Davison SN, Rathwell S, Ghosh S, George C, Pfister T, Dennett L. The prevalence and severity of chronic pain in patients with chronic kidney disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2021;8:2054358121993995. DOI: https://doi.org/10.1177/2054358121993995
Fleishman TT, Dreiher J, Shvartzman P. Pain in maintenance hemodialysis patients: a multicenter study. J Pain Symptom Manage. 2018;56(2):178-84. DOI: https://doi.org/10.1016/j.jpainsymman.2018.05.008
Dos Santos PR, Mendonça CR, Noll M, Borges CC, Alves PM, Dias NT, et al. Pain in hemodialysis patients: prevalence, intensity, location, and functional interference in daily activities. Healthcare. 2021;9(10):1375. DOI: https://doi.org/10.3390/healthcare9101375
Ezzat S, Tharwat S, Abdelsalam S, Eltoraby EE. Musculoskeletal symptoms in hemodialysis patients and their effect on health-related quality of life. Blood Purif. 2020;49(3):289-94. DOI: https://doi.org/10.1159/000504038
Davison SN, Jhangri GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39(3):477-85. DOI: https://doi.org/10.1016/j.jpainsymman.2009.08.008
Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manage. 2005;30(5):465-73. DOI: https://doi.org/10.1016/j.jpainsymman.2005.05.013
Hage S, Hage V, El-Khoury N, Azar H, Chelala D, Ziadé N. Musculoskeletal disorders in hemodialysis patients: different disease clustering according to age and dialysis vintage. Clin Rheumatol. 2020;39(2):533-9. DOI: https://doi.org/10.1007/s10067-019-04786-w
Kidney Disease: Improving Global Outcomes CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder. Kidney Int. 2017;7(1):1-59. DOI: https://doi.org/10.1016/j.kisu.2017.04.001
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes. Kidney Int. 2006;69(11):1945-53. DOI: https://doi.org/10.1038/sj.ki.5000414
Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913-21. DOI: https://doi.org/10.2215/CJN.06040710
Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study. Am J Kidney Dis. 2008;52(3):519-30. DOI: https://doi.org/10.1053/j.ajkd.2008.03.020
Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol. 2008;19(11):2193-203. DOI: https://doi.org/10.1681/ASN.2008010014
Lim CY, Ong KO. Various musculoskeletal manifestations of chronic renal insufficiency. Clin Radiol. 2013;68(7):e397-411. DOI: https://doi.org/10.1016/j.crad.2013.01.025
Sabry R, Tharwat S, Nassar MK, Eltoraby EE. Ultrasonographic assessment of entheseal sites of upper and lower extremities in hemodialysis patients using Madrid Sonography Enthesitis Index. BMC Musculoskelet Disord. 2022;23(1):606. DOI: https://doi.org/10.1186/s12891-022-05512-5
Sadigova E, Ozkurt S, Yalcin AU. Pain assessment in hemodialysis patients. Cureus. 2020;12(2):e6903. DOI: https://doi.org/10.7759/cureus.6903
Rao Q, Zeng J, Wang S, Hao J, Jiang M. Chronic pain and quality of life in maintenance hemodialysis patients in China: a multicenter, cross-sectional study. J Pain Res. 2022;15:147-57. DOI: https://doi.org/10.2147/JPR.S345610
Samoudi AF, Marzouq MK, Samara AM, Zyoud SH, Al-Jabi SW. The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine. Health Qual Life Outcomes. 2021;19(1):39. DOI: https://doi.org/10.1186/s12955-021-01686-z
Mrabet S, Attia S, Chaieb R. Pain assessment, management and impact among hemodialysis patients: a study from Tunisia. BMC Nurs. 2025;24:581. DOI: https://doi.org/10.1186/s12912-025-03130-9
Nassar MK, Tharwat S, Abdel-Gawad SM, Elrefaey R, Elsawi AA, Elsayed AM, et al. Symptom burden, fatigue, sleep quality and perceived social support in hemodialysis patients with musculoskeletal discomfort: a single center experience from Egypt. BMC Musculoskelet Disord. 2023;24(1):788. DOI: https://doi.org/10.1186/s12891-023-06910-z
Kurer MH, Baillod RA, Madgwick JC. Musculoskeletal manifestations of amyloidosis: a review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br. 1991;73(2):271-6. DOI: https://doi.org/10.1302/0301-620X.73B2.2005153
Fukuda K, Yamamoto H. Dialysis-related amyloidosis. Semin Musculoskelet Radiol. 2001;5(2):113-9. DOI: https://doi.org/10.1055/s-2001-15879
Wang JS, Chiang JH, Hsu HJ. Lower risk of musculoskeletal pain among patients with end-stage renal disease treated by hemodialysis: a frequency-matched retrospective cohort study. Medicine. 2018;97(33):e11935. DOI: https://doi.org/10.1097/MD.0000000000011935
Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: visual analog scale for pain, numeric rating scale for pain, McGill Pain Questionnaire, Short-Form McGill Pain questionnaire, chronic pain grade scale, short form-36 bodily pain scale, and measure of intermittent and constant osteoarthritis pain. Arthritis Care Res. 2011;63(11):S240-52. DOI: https://doi.org/10.1002/acr.20543
Weisbord SD. Patient-centered dialysis care: depression, pain, and quality of life. Semin Dial. 2016;29(2):158-64. DOI: https://doi.org/10.1111/sdi.12464
Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;64(1):339-49. DOI: https://doi.org/10.1046/j.1523-1755.2003.00072.x
Shayamsunder AK, Patel SS, Jain V, Peterson RA, Kimmel PL. Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients. Semin Dial. 2005;18(2):109-18. DOI: https://doi.org/10.1111/j.1525-139X.2005.18218.x
Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr. 2007;17(6):381-8. DOI: https://doi.org/10.1053/j.jrn.2007.08.008
Matos CM, Silva LF, Santana LD, Santos LS, Protásio BM, Rocha MT, et al. Handgrip strength at baseline and mortality risk in a cohort of women and men on hemodialysis: a 4-year study. J Ren Nutr. 2014;24(3):157-62. DOI: https://doi.org/10.1053/j.jrn.2013.12.005
Roy PJ, Weltman M, Dember LM, Liebschutz J, Jhamb M. Pain management in patients with chronic kidney disease and end-stage kidney disease. Curr Opin Nephrol Hypertens. 2020;29(6):671-80. DOI: https://doi.org/10.1097/MNH.0000000000000646
Lu E, Koncicki HM. Nonopioid approaches to pain management in patients with kidney disease. Semin Nephrol. 2021;41(1):54-67. DOI: https://doi.org/10.1016/j.semnephrol.2021.02.006
Ishida JH, McCulloch CE, Steinman MA, Grimes BA, Johansen KL. Opioid analgesics and adverse outcomes among hemodialysis patients. Clin J Am Soc Nephrol. 2018;13(5):746-53. DOI: https://doi.org/10.2215/CJN.09910917
Pu J, Jiang Z, Wu W, Li L, Zhang L, Li Y, et al. Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e020633. DOI: https://doi.org/10.1136/bmjopen-2017-020633
Sheng K, Zhang P, Chen L, Cheng J, Wu C, Chen J. Intradialytic exercise in hemodialysis patients: a systematic review and meta-analysis. Am J Nephrol. 2014;40(5):478-90. DOI: https://doi.org/10.1159/000368722
Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, et al. SONG-HD Investigators. Establishing core outcome domains in hemodialysis: report of the Standardized Outcomes in Nephrology-Hemodialysis consensus workshop. Am J Kidney Dis. 2017;69(1):97-107. DOI: https://doi.org/10.1053/j.ajkd.2016.05.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Maulik Patel, Gaurang Patel

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.